Tailoring Advanced Metal‐Based Nanomedicines for Adaptable Nanodynamic Disease Therapies and Theranostics
Advanced Materials · 2026-01 · 38 (1)
DOI: 10.1002/adma.202513609 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Advanced Materials, online erschienen am 15.09.2025. Verfasst von Qihang Ding und 11 weiteren Autor:innen. Beteiligte Einrichtung: Engineering Research Center for Pharmaceuticals and Equipments of Sichuan Province, Sichuan Industrial Institute of Antibiotics, School of Pharmacy, …. Hauptthemen laut MEDLINE: Theranostic Nanomedicine, Metals, Nanomedicine, Nanostructures. Die Arbeit wurde bisher 36-mal zitiert (Crossref) und nennt 208 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: China Scholarship Council, National Natural Science Foundation of China, Shandong Laboratory Program.
Abstract (Originalsprache)
Advanced metal‐based nanomaterials (MBNs) represent a dynamic frontier in nanomedicine, offering a versatile platform for next‐generation diagnostics and therapeutics. Their tunable structures and catalytic, optical, and magnetic properties enable diverse nanodynamic therapies (NDTs), including photodynamic, chemodynamic, sonodynamic, thermodynamic, piezoelectric, radiodynamic, and magnetodynamic modalities. In addition to the well‐established tumor ablation, MBNs also feature potent antimicrobial and antiviral activity, functioning via reactive oxygen species generation, immune modulation, and biofilm disruption. Recent developments in metal–organic frameworks, metal–phenolic networks, and 2D metal nanosheets have expanded the toolkit for precision drug delivery, imaging‐guided therapy, and bioresponsive release strategies. This comprehensive review highlights the structural design principles, therapeutic mechanisms, and versatile biomedical applications of emerging MBN platforms, emphasizing synergistic treatment strategies and their role in overcoming hypoxia, multidrug resistance, and immunosuppression. Despite their promise, clinical translation remains hindered by unresolved issues in long‐term biosafety, biodegradation, and scalable manufacturing. Future efforts are expected to focus on tailoring intelligent nanostructures with optimized pharmacokinetics, integrating multimodal imaging with real‐time therapeutic feedback, and ensuring regulatory compliance. Continued innovation at the interface of materials science, biology, and medicine will be essential for transforming MBN‐based systems into clinically viable tools for oncology, infectious disease control, and personalized medicine.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Engineering Research Center for Pharmaceuticals and Equipments of Sichuan Province, Sichuan Industrial Institute of Antibiotics, School of Pharmacy, Chengdu University, Chengdu, 610106, China.
- Department of Chemistry, Korea University, Seoul, 02841, South Korea.
- Health Center, Sichuan Cancer Hospital and Institute, Sichuan Cancer Center, Affiliated Cancer Hospital of University of Electronic Science and Technology of China, Chengdu, 610041, China.
- Materdicine Lab, School of Life Sciences, Shanghai University, Shanghai, 2000444, China.
- Department of Medical Oncology, Sichuan Cancer Center, School of Medicine, Sichuan Cancer Hospital and Institute, University of Electronic Science and Technology of China, Chengdu, 610041, China.
ORCID-Profile: Qihang Ding, Yu Chen
Förderung
- China Scholarship Council
- National Natural Science Foundation of China
- Shandong Laboratory Program
- Gansu Science and Technology Major Project
- Strategic Priority Research Program of the Chinese Academy of Sciences
- Open Subject Funding of Sichuan Engineering and Technology Research Center for Industrialization of Antiviral Chinese Medicines of Sichuan Guangda Pharmaceutic…
- Chinese Southwest Oncology Group, Clinical Research
- Health Commission of Sichuan Province, Science and Technology Project
Zitieren
APA
Ding, Q., Li, W., Mei, L., Luo, S., Tao, J., Shi, C., Yang, H., Feng, W., Chen, Y., Chen, Y., Kim, J. S., & Shen, X. (2026). Tailoring Advanced Metal‐Based Nanomedicines for Adaptable Nanodynamic Disease Therapies and Theranostics. Advanced Materials, 38(1). https://doi.org/10.1002/adma.202513609
Vancouver
Ding Q, Li W, Mei L, Luo S, Tao J, Shi C, et al. Tailoring Advanced Metal‐Based Nanomedicines for Adaptable Nanodynamic Disease Therapies and Theranostics. Advanced Materials. 2026;38(1). doi:10.1002/adma.202513609
BibTeX
@article{Ding2026,
author = {Ding, Qihang and Li, Wenhao and Mei, Ling and Luo, Suling and Tao, Jing and Shi, Chongxiu and Yang, Hongping and Feng, Wei and Chen, Yungchang and Chen, Yu and Kim, Jong Seung and Shen, Xue},
title = {Tailoring Advanced Metal‐Based Nanomedicines for Adaptable Nanodynamic Disease Therapies and Theranostics},
journal = {Advanced Materials},
year = {2026},
volume = {38},
number = {1},
doi = {10.1002/adma.202513609}
}
EUVIMED